Ping An Biomedical Co. Ltd. (Class A) (PASW) Options Positioning, Max Pain & Unusual Sweeps

$5.00 -0.20% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot)

Ping An Biomedical Co. Ltd. (Class A) (PASW) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E β€’ RED ALERT Cap $15.6M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERRED ALERT β€’ E
025507510034
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E Β· Rk D-
Cash (10)Whales (7)SEC (8)Macro (6)CEO (3)
Each axis scored 0–20
12M PRICE TARGET CONE-10.8% Base Target
$31 Bull$4 Base$3 Bear
πŸ“¬ FREE PASW RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for PASW)Realized 20D OHLCV Swing Band: Β±12.5%
CALL VS. PUT WHALE SHARE
β€” (No Active Options Snapshot)
Put/Call Ratio: β€” (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
β€” (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
Β±12.5%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (PASW)

β€” (No Active Options Snapshot) β€” No unusual CBOE strike concentration anomalies recorded in the current database snapshot for PASW.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

πŸ† Enter Free $100K Paper Arena β†’
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PASW)

  • βœ“Walkthrough of PASW's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PASW // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -20.38%πŸ“ HORIZONTAL RANGE
2026-10-30O $5.33H $5.53L $4.30C $5.00VOL 62.3K
RES: $10.83SUP: $2.88SMA50: $5.15SMA200: $6.11
$29.08$22.03$14.98$7.93$0.88RES $10.83SUP $2.88$5.002026-04-302026-06-152026-07-312026-09-162026-10-30
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PASW Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PASW today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for PASW. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PASW today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PASW)

Consumer Discretionary Rank #923 of 1011 βš”οΈ TLF vs PASW Full Matrix β†’

1. Head-to-Head Consumer Discretionary Peer Comparison (PASW vs. TLF, BIRD, NCI, BRIA)

Industry: Apparel (27 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Ping An Biomedical Co. Ltd. (Class A) (PASW) ranks #923 by composite RQD confidence (34/100, grade E) and #897 by equity capitalization ($15.6M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. BRIA currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with PASW at 34/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PASW ACTIVE
Ping An Biomedical Co. Ltd. (Class A)
E 34/100 β€” 2.8% β€” -0.20% $15.6M Benchmark Subject
TLF
Tandy Leather Factory Inc.
D- 43/100 β€” 57.0% -2.1% +0.44% $18.5M /tlf-vs-pasw β†’
BIRD
Smartbird Inc. (Class A)
D- 37/100 β€” 41.0% -35.0% -0.93% $25.0M /bird-vs-pasw β†’
NCI
Neo-Concept International Group Holdings Limited (Class A)
D- 42/100 153.8x 36.9% 2.6% -1.68% $6.6M /nci-vs-pasw β†’
BRIA
BrilliA Inc (Class A)
D+ 56/100 β€” β€” β€” -4.11% $42.9M /bria-vs-pasw β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2025–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-09-30 β€’ CIK 0001897532

In its most recent audited fiscal period (FY2025, filed 2025-09-30), Ping An Biomedical Co. Ltd. (Class A) (PASW) reported GAAP revenue of $4.8M , GAAP net income of -$1.8M, operating cash flow of -$902.9K, and free cash flow of -$902.9K . On the balance sheet, PASW closed FY2025 with $9.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 1/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-09-30 $4.8M -$1.8M -$902.9K -$902.9K $9.6M β€”

3. PASW Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PASW stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Ping An Biomedical Co. Ltd. (Class A) (NASDAQ: PASW) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $5.00 (-0.20% 1D, market cap $15.6M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1011 tracked Consumer Discretionary issuers, PASW ranks #923 in composite RQD confidence.

How does PASW compare to TLF and BIRD in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), PASW carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 2.8%, and ROIC of β€”. By comparison, TLF (Tandy Leather Factory Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -2.1%, cap $18.5M) and BIRD (Smartbird Inc. (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $25.0M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PASW?

Per PASW's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001897532), Ping An Biomedical Co. Ltd. (Class A) generated $4.8M in revenue, -$1.8M in net income, and -$902.9K in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PASW trading relative to its 50-day, 200-day, and 52-week technical levels?

PASW last traded at $5.00 (-0.20% on volume of 64,106 shares), positioning the stock -2.91% below its 50-day simple moving average ($5.15) and -18.17% below its 200-day simple moving average ($6.11). Across its 52-week range of $3.07 to $29.28, PASW sits at the 7.4% percentile with a 14-day RSI of 51.7 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($4.37 to $5.63).

PASW Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

What is PASW's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for PASW.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $213.66 -0.80% AAPL $348.91 +1.48% MSFT $530.14 -0.16% TSLA $403.30 -0.23% PLTR $196.42 -0.20% SOFI $17.61 +2.74% IBIT $43.36 -0.94% GLD $355.78 -1.34%